Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus

Keyphrases

• Recombinant Adenovirus 100%
• Growth Suppression 100%
• P16 Gene 100%
• Human Ovarian Cancer Cells 100%
• Adenovirus 40%
• Ovarian Cancer Cells 40%
• G1 Arrest 40%
• SKOV3 40%
• P16 Protein 40%
• Cell Growth 20%
• Apoptosis 20%
• Escherichia Coli 20%
• β-Galactosidase (β-Gal) 20%
• Infected Cells 20%
• Potential Therapeutics 20%
• Attenuation 20%
• Every Other Day 20%
• Ovarian Cancer 20%
• Cyclin-dependent Kinase Inhibitor 2A (CDKN2A) 20%
• Cell Count 20%
• Counting Cells 20%
• Fluorescence-activated Cell Sorting 20%
• Morphological Changes 20%
• Western Blotting 20%
• Multiple Tumors 20%
• Multiplicity of Infection 20%
• Tumor Suppressor 20%
• P16 Expression 20%
• Cyclin-dependent Kinase 4 (CDK4) 20%
• Cell Cycle Arrest 20%
• Propidium Iodide 20%
• G1 Checkpoint 20%
• Recombinant Adeno-associated Virus (rAAV) 20%
• Transduction Efficiency 20%
• Cell Cycle Proteins 20%
• X-gal 20%
• Cyclin D 20%
• Inhibiting Activity 20%
• P16 Deletion 20%
• Cyclin-dependent Kinase 4 Inhibitor 20%
• P16 Status 20%

Immunology and Microbiology

• Adenoviridae 100%
• Tumor Suppressor Gene 100%
• Growth Inhibition 100%
• Ovarian Cancer Cell Line 100%
• Cell Line 60%
• G1 Phase Cell Cycle Checkpoint 60%
• Cell Cycle 40%
• Staining 40%
• Cell Growth 20%
• Escherichia coli 20%
• Western Blot 20%
• Adenovirus Vector 20%
• Cycline 20%
• Cell Count 20%
• Cell Cycle Checkpoint 20%
• Morphology 20%
• Protein Expression 20%
• Fluorescence Activated Cell Sorting 20%
• Infectious Disease 20%
• Multiplicity of Infection 20%
• Cell Cycle Arrest 20%
• Propidium Iodide 20%
• Cyclin D 20%
• OVCA420 Cell Line 20%
• Programmed Cell Death 20%
• Infection 20%
• Phosphotransferase 20%
• Kinase 20%
• Galactosidase 20%